omniture
QBIOTICS GROUP LIMITED

Latest News

QBiotics' STELFONTA® Receives FDA Approval for Canine Mast cell Tumours

* STELFONTA (tigilanol tiglate injection) is now approved by the U.S. Food and Drug Administration...

2020-11-17 11:51 3070

QBiotics commercialises first tigilanol tiglate pharmaceutical product with launch of STELFONTA®

BRISBANE, Australia, April 28, 2020 /PRNewswire/ -- Australian life sciences company, QBiotics Grou...

2020-04-28 14:43 1358

QBiotics receives first registration for tigilanol tiglate with European Medicines Agency approval of Stelfonta(R)

* STELFONTA® (tigilanol tiglate) approved by the European Medicines Agency (EMA), making it the f...

2020-01-20 07:00 3356

Publication of First In-Human Data Reveals Safety & Efficacy of Tigilanol Tiglate in Solid Tumours

* First in-human Clinical Phase I study of intratumoural tigilanol tiglate (EBC-46) has been publ...

2019-12-09 21:01 1450